Differences

This shows you the differences between two versions of the page.

Link to this comparison view

start [2016/10/18 14:39]
f.demichelis@unitn.it
start [2017/06/06 15:46] (current)
f.demichelis@unitn.it
Line 4: Line 4:
  
 The laboratory integrates computational and experimental work and is characterized by inter-disciplinary/inter-institutional collaborations that allow for a challenging and stimulating atmosphere and state-of-the-art approaches. The laboratory integrates computational and experimental work and is characterized by inter-disciplinary/inter-institutional collaborations that allow for a challenging and stimulating atmosphere and state-of-the-art approaches.
 +
 +Follow us on {{:twitter.png?30|[[https://twitter.com/FrancescaBZNY]]}}
  
 <html>  <html> 
Line 11: Line 13:
 </html> </html>
  
 +
 +**June 5th 2017**: **ASCO 2017** Whole exome sequencing of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer presented at ASCO 2017 was featured in UroToday. Collaboration with Weill Cornell Medicine.([[https://www.urotoday.com/conference-highlights/asco-2017/asco-2017-prostate-cancer/96283-asco-2017-whole-exome-sequencing-of-circulating-tumor-dna-ctdna-in-patients-with-neuroendocrine-prostate-cancer-informs-tumor-heterogeneity.html|article]]).
 +
 +----
 {{ :nature_genetics.jpg?nolink&130}} {{ :nature_genetics.jpg?nolink&130}}
 **October 17th 2016**: [[http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3692.html|Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma]] Chemotherapy drives treatment resistance in bladder cancer as revealed by allele-specific CLONET based analysis of bladder cancer tissues. An international team-science collaborative work with Weill Cornell Medicine and the Englander Institute for Precision Medicine ([[http://weill.cornell.edu/news/news/2016/10/chemotherapy-drives-treatment-resistance-in-bladder-cancer.html|press release]]). **October 17th 2016**: [[http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3692.html|Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma]] Chemotherapy drives treatment resistance in bladder cancer as revealed by allele-specific CLONET based analysis of bladder cancer tissues. An international team-science collaborative work with Weill Cornell Medicine and the Englander Institute for Precision Medicine ([[http://weill.cornell.edu/news/news/2016/10/chemotherapy-drives-treatment-resistance-in-bladder-cancer.html|press release]]).